Eleven years of experience with bisphosphonate plus alfacalcidol treatment in a man with osteogenesis imperfecta type I

about

Eleven years of experience with bisphosphonate plus alfacalcidol treatment in a man with osteogenesis imperfecta type I

Item

http://www.wikidata.org/entity/Q36500182

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Eleven years of experience wit ...... osteogenesis imperfecta type I

@ast

Eleven years of experience wit ...... osteogenesis imperfecta type I

@en

type

Item

label

Eleven years of experience wit ...... osteogenesis imperfecta type I

@ast

Eleven years of experience wit ...... osteogenesis imperfecta type I

@en

prefLabel

Eleven years of experience wit ...... osteogenesis imperfecta type I

@ast

Eleven years of experience wit ...... osteogenesis imperfecta type I

@en

P1476

Eleven years of experience wit ...... osteogenesis imperfecta type I

@en

P2093

Hideo Matsumoto

http://www.w3.org/2001/XMLSchema#string

Jun Iwamoto

http://www.w3.org/2001/XMLSchema#string

Mitsuyoshi Uzawa

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Sato

http://www.w3.org/2001/XMLSchema#string

P2860

Quality of life and pain in premenopausal women with major depressive disorder: the POWER Study.

Continuing bisphosphonate treatment for osteoporosis--for whom and for how long?

Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study.

Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.

Bisphosphonates for osteoporosis--where do we go from here?

Diagnostic criteria for primary osteoporosis: year 2000 revision.

Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta

Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial).

Bisphosphonate therapy for severe osteogenesis imperfecta.

Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study.

P304

1-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.2147/TCRM.S38404

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23293527

http://www.w3.org/2001/XMLSchema#string

P921

osteogenesis imperfecta

P932

3534324

http://www.w3.org/2001/XMLSchema#string